Open access
Open access
Powered by Google Translator Translator

Daily Archives: December 3, 2020

UK becomes first country to authorize Pfizer/BioNTech’s Covid-19 vaccine, first shots roll out next week

3 Dec, 2020 | 08:44h | UTC

UK becomes first country to authorize Pfizer/BioNTech’s Covid-19 vaccine, first shots roll out next week – CNN

Press release: UK medicines regulator gives approval for first UK COVID-19 vaccine – Medicines and Healthcare products Regulatory Agency

See also: Covid-19: Pfizer/BioNTech vaccine judged safe for use in UK – BBC AND Expert reaction to news that the MHRA has approved the Pfizer/BioNTech COVID-19 vaccine for mass UK roll out – Science Media Centre AND UK approves Pfizer/BioNTech Covid vaccine for rollout next week – The Guardian

 


WHO Solidarity Trial: Remdesivir, hydroxychloroquine, lopinavir, and interferon regimens had little or no effect on hospitalized patients with Covid-19

3 Dec, 2020 | 08:47h | UTC

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results – New England Journal of Medicine

Audio Interview: Caring for Hospitalized Patients with Covid-19

 

Commentary on Twitter (thread – click for more)

 


Review: Cytokine Storm

3 Dec, 2020 | 08:46h | UTC

Cytokine Storm – New England Journal of Medicine

 

Commentary on Twitter

 


Randomized trial: In treatment naive early rheumatoid arthritis, a treatment based on methotrexate and low dose corticosteroids was safe and effective and non-inferior to certolizumab and tocilizumab, but not to abatacept

3 Dec, 2020 | 08:35h | UTC

Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial – The BMJ

 


CDC to shorten COVID-19 quarantine to 10 days, 7 with test

3 Dec, 2020 | 08:40h | UTC

CDC to shorten COVID-19 quarantine to 10 days, 7 with test – Associated Press

Commentary: CDC Shortens Its COVID-19 Quarantine Recommendations – NPR

 


Special Report: The Covid-19 vaccines are a marvel of science. Here’s how we can make the best use of them

3 Dec, 2020 | 08:42h | UTC

The Covid-19 vaccines are a marvel of science. Here’s how we can make the best use of them – STAT

 


Meta-analysis: Oxytocin used as first‐line treatment of postpartum hemorrhage probably is more effective than misoprostol with less side‐effects. The evidence for most other uterotonic agents is limited.

3 Dec, 2020 | 08:31h | UTC

Uterotonic agents for first‐line treatment of postpartum haemorrhage: a network meta‐analysis – Cochrane Library

Summary: Which drug is best for treating excessive bleeding after childbirth? – Cochrane Library

 


Randomized trial: In areas with intense malaria transmission, postdischarge malaria chemoprevention in children recently treated for severe anemia prevented deaths and readmissions

3 Dec, 2020 | 08:33h | UTC

Malaria Chemoprevention in the Postdischarge Management of Severe Anemia – New England Journal of Medicine

Visual abstract: Malaria Chemoprevention for Management of Severe Anemia

 


Guideline for the perioperative management of hip fractures 2020

3 Dec, 2020 | 08:30h | UTC

Guideline for the management of hip fractures 2020 – Anaesthesia

 

Commentary on Twitter

 


Review: Perioperative venous thromboembolism prophylaxis

3 Dec, 2020 | 08:28h | UTC

Perioperative Venous Thromboembolism Prophylaxis – Mayo Clinic Proceedings

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.